Skip to main content
. 2021 Apr 22;13(5):605. doi: 10.3390/pharmaceutics13050605

Figure 5.

Figure 5

Tamsulosin release from PEG–PTMC solution (F09) and suspension (F10) formulations with the same type and content of triblock PEG–PTMC (TB1-9.3_40.0%).